Form 8-K - Current report:
SEC Accession No. 0001140361-24-011945
Filing Date
2024-03-07
Accepted
2024-03-07 16:05:26
Documents
14
Period of Report
2024-03-05
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K ef20023567_8k.htm   iXBRL 8-K 32116
  Complete submission text file 0001140361-24-011945.txt   169461

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA kron-20240305.xsd EX-101.SCH 3868
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE kron-20240305_lab.xml EX-101.LAB 21966
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kron-20240305_pre.xml EX-101.PRE 16046
15 EXTRACTED XBRL INSTANCE DOCUMENT ef20023567_8k_htm.xml XML 4227
Mailing Address 1300 S. EL CAMINO REAL SUITE 400 SAN MATEO CA 94402
Business Address 1300 S. EL CAMINO REAL SUITE 400 SAN MATEO CA 94402 (650) 781-5200
Kronos Bio, Inc. (Filer) CIK: 0001741830 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39592 | Film No.: 24730037
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)